DPT Laboratories, Ltd. 318 McCullough San Antonio, TX 78215 Tel: (210) 476-8150

EX-10.17 13 d153565dex1017.htm EX-10.17 EX-10.17

Exhibit 10.17

***Text Omitted and Filed Separately

with the Securities and Exchange Commission.

Confidential Treatment Requested

Under 17 C.F.R. Sections 200.80(b)(4)

and 230.406.


DPT Laboratories, Ltd. 318 McCullough San Antonio, TX 78215 Tel: (210) 476-8150	April 9, 2012 Ashok Chavan, Ph.D. Insys Therapeutics, Inc. 10220 South 51^st Street, Suite 2 Phoenix, AZ 85044 Re: Contract Manufacturing Agreement dated May 24, 2011 between INSYS THERAPEUTICS, INC. and DPT LABORATORIES, LTD. (“Manufacturing Agreement”) Dear Ashok: This letter is to confirm our mutual agreement to amend the prices of the above-captioned Agreement from January 1, 2012 through December 31, 2012. We have agreed that the prices shall be revised as set forth in Schedule A attached hereto. All other terms and conditions contained in the said Agreement thereto shall remain in full force and effect. If this meets with your understanding and agreement, please sign and date below, retaining an original and returning the other original to my attention by April 20, 2012.
			Yours truly,

	ACCEPTED AND AGREED TO THIS 23rd DAY OF APRIL, 2012		DPT LAKEWOOD, LLC

	By:	/s/ Michael Babich	By:	/s/ Paul Josephs
	Print Name:	Michael Babich		Paul Josephs
	Title:	CEO		Vice President of Sales &
				Marketing
	Page 1 of 3 Confidential


Schedule A - 2012 - Revision #2 - March 30, 2012

Client - #713 INSYS Therapeutics, Inc.

PRODUCT

CODE

PRODUCT DESCRIPTION

ANNUAL
QUANTITY
(Spray
Devices)

ORDER
QUANTITY
(Batch Size)
(Spray
Devices)

Batch
Size

# of
BATCHES
per ORDER

# of
BATCHES
per YEAR

MANUFACTURING
PRICE per spray
device($)

MATERIAL
PRICE per
spray device
($)

TOTAL
PRICE
per spray
device
US $

MANUFACTURING
PRICE per carton($)

MATERIAL
PRICE per
carton($)

TOTAL
PRICE
per carton
US $

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

[…***…]

SUBSYS^®(fentanyl sublingual spray) […***…]

[…***…]

$[…***…]

[…***…]

$[…***…]

[…***…]

Notes:

1)	Manufacturing and Materials Fee’s are based on […***…].

2)	Pricing to be effective: […*…] through […*…].

Any and all products to be delivered on or after […***…] will be subject to new pricing.

3)	Client orders are based […***…].

4)	The Material Fee is […***…]. THE API is supplied by the INSYS Therapeutics.

5)	Material Handling Fee is […*…]% […*…].

6)	Pricing is […***…].

Page 2 of 3

Confidential

***Confidential Treatment Requested


Schedule A - 2012 - Revision #2 - March 30, 2012

Client - #713 INSYS Therapeutics, Inc.

[…***…].

8)	The original Schedule A dated June 1, 2011 […***…].

[…***…].

10)	The launch of SUBSYS^® products will be March 2012.

11)

[…***…].

12)

[…***…].


INSYS Therapeutics, Inc.		DPT Lakewood, LLC

By:	/s/ Michael Babich	By:	/s/ Paul Josephs
Print Name:	Michael Babich	Print Name:	Paul Josephs
Title:	CEO	Title:	VP Sales & Mktg
Date:	4/23/12	Date:	4/9/12

Page 3 of 3

Confidential

***Confidential Treatment Requested